About

A Legacy of Trusted Pharmaceutical Distribution Since 1978

Pan American Exports LLC began exporting specialty medicines into Mexico in May 1978, the mission then was to supply unavailable specialty pharmaceuticals into Mexico. Over the decades, the company has strategically expanded its operational footprint throughout Latin America with key acquisitions and mergers:

• 1982: Merged with Rx Medical Warehouse
• 1994: Acquired Punlab de México SA
• 2005: Merged with Pro-Medical SA
• 2020: Consolidated Export Warehousing
• 2022: Reorganized Mexico City Pharma Operations

Who We Are Today

Pan American Exports LLC serves as a licensed pharmaceutical exporter and global procurement office. Specializing in the international distribution of pharmaceutical products:

• Finished and semi-finished pharmaceutical products
• Biosimilar Treatments
• Biologic Plasma Products
• Vaccines and Immuno-therapies

We do not operate analytical testing or packaging facilities — making us ineligible for direct GMP certification. Pan American Exports LLC serves as an authorized commercial agent and international distributor for a consortium of GMP-certified manufacturers holding {WHO, FDA, EMA, & COFEPRIS Authorisations}

Our Quality Commitment

Products sourced exclusively from licensed, regulated, and GMP-certified manufacturers. We enforce strict compliance with Good Distribution Practices (GDP), including:

• Cold-chain management (where applicable)
• Complete batch and lot traceability
• Alignment with international regulatory documentation standards
• Controlled and compliant export handling

Most shipments are accompanied by appropriate supporting documents such as:

• Commercial Invoice
• Free Sale Authorisation
• GMP Certification(s)
• Packing Lists
• Documented Regulatory Approvals
• Proper Transport and Customs Declarations

Transparency and Client Support

Should your procurement office require additional verification, technical documentation, or direct coordination with a manufacturing site, Pan American Exports LLC is fully prepared to facilitate direct engagement with the respective production facility. Our commitment is to maintain:

• Regulatory transparency
• Supply chain integrity
• Full compliance with global pharmaceutical standards